34
Participants
Start Date
October 31, 2005
Primary Completion Date
June 30, 2008
Study Completion Date
June 30, 2008
mesalamine
oral tablet, 30 mg mesalamine/day for 28 days
mesalamine
oral tablet, 60 mg mesalamine/day for 28 days
mesalamine
oral tablet, 90 mg mesalamine/day for 28 days
Research Site, Buffalo
Research Site, Boston
Research Site, Baltimore
Research Site, Greenville
Research Site, Jacksonville
Research Site, Gainesville
Research Site, Birmingham
Research Site, Cleveland
Research Site, Cincinnati
Research Site, Detroit
Research Site, Park Ridge
Research Site, Mobile
Research Site, Omaha
Research Site, Dallas
Research Site, Houston
Research Site, Pasadena
Research Site, San Diego
Research Site, Costa Mesa
Research Site, San Francisco
Research Site, Portland
Research Site, Seattle
Research Site, Morristown
Lead Sponsor
Warner Chilcott
INDUSTRY